Company: EVGN
Filing Date: 2025-03-28
Form Type: S-8
Source: 0001178913-25-001098
Chunk: 2

Company: Evogene Ltd.
Filing Date: 2025-03-28
Form: S-8
Chunk 2
---
 on June 23, 2021. |

SIGNATURES Pursuant to the requirements of the Securities Act of 1933, as amended, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8, and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Tel Aviv, Israel, on this 27 thday of March, 2025.

| Evogene Ltd. |                 |
| By:          | /s/ Yaron Eldad |
| Name:        | Yaron Eldad     |
| Title:       | CFO             |

POWER OF ATTORNEY We, the undersigned directors and/or officers of the Registrant, hereby severally constitute and appoint Mr. Ofer Haviv, Chief Executive Officer and President, and Mr. Yaron Eldad, Chief Financial Officer, and each of them singly, our true and lawful attorneys, with full power to any of them, and to each of them singly, to sign for us and in our names in the capacities indicated below the registration statement on Form S-8 filed herewith, and any and all amendments to said registration statement, and any registration statement filed pursuant to Rule 462(b) under the Securities Act, and to file or cause to be filed the same, with all exhibits thereto and other documents in connection therewith, with the Commission, granting unto said attorneys, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully to all intents and purposes as each of them might or could do in person, and hereby ratifying and confirming all that said attorneys, and each of them, or their substitute or substitutes, shall do or cause to be done by virtue of this Power of Attorney. Pursuant to the requirements of the Securities Act of 1933, as amended, this Registration Statement has been signed by the following persons in the capacities indicated on March 27, 2025.

| Name              |     | Title                              |
| /s/ Ofer Haviv    |     | CEO and President                  |
| /s/ Nir Nimrodi   |     | Chairman of the Board of Directors |
| /s/ Leon Recanati |     | Director                           |
| /s/ Dan Falk      |     | Director                           |
| /s/ Adrian Percy  |     | Director